InvestorsHub Logo
Followers 1077
Posts 90220
Boards Moderated 8
Alias Born 07/26/2007

Re: None

Saturday, 04/06/2013 5:48:21 PM

Saturday, April 06, 2013 5:48:21 PM

Post# of 174
Only 9,778,940 shares OS.

The MV at the recent high $0.01 is just $97K which is still joke low as a CH11 bio-tech. company or a clean RM shell!

Note, the available float for trading is less than 1M shares which is super tiny!

The cash value is $2.47M or $0.25 per share.

The revenue is $1.5M or $0.22 per share.

The gross profit is $681K.

The enterprise value is $6,360,000 or $0.6504 per share!

The insiders ownership is 0.6% of OS!


Key technical updating: The 20/50/200-Day MAL is 0.0011/0.0011/0.0015.



The two-year high was 0.07.



The company website: http://www.ivysportsmed.com/



ReGen Biologics, Inc. (RGBOQ) Business Summary:

ReGen Biologics, Inc. designs, develops, manufactures, and markets medical devices for the repair and generation of soft tissue in humans, primarily for orthopedic applications. The company's proprietary collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular, and drug delivery. Its products include Menaflex collagen meniscus implant device, for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus; and SharpShooter Tissue Repair System, an instrument that allows surgeons to place needles in hard-to-reach locations of the meniscus. The company sells its products in the United States, the European Union, the Republic of South Africa, Canada, Australia, Chile, and Japan. ReGen Biologics, Inc. was founded in 1987 and is headquartered in Hackensack, New Jersey.

There are fifteen full-time employees with the company.

OTC-Killers-Club has spot 182 stock killers from 4900-bagger to 2.33-bagger since 03/05/2011

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.